Peter Noseworthy

65PUBLICATIONS
383CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational physiologyRespiratory diseasesMedical biotechnology diagnostics (incl. biosensors)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Apr 24, 2026
First-in-Human Clinical Experience With Focal Pulsed Field and Radiofrequency Dual-Modality Ablation for Treatment Refractory Left Ventricular Summit PVCs.

|Mar 12, 2026
Artificial intelligence 12-lead electrocardiography to determine atrial fibrillation risk among UK Biobank participants with predisposing conditions.

Yi Zheng, Konstantinos C Siontis, Zachi I Attia

|Feb 24, 2026
Multimorbidity in Atrial Fibrillation: Impact on Outcomes.

Sheila M Manemann, Alvaro Alonso, Peter A Noseworthy

|Feb 10, 2026
Author Correction: Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial.

Douglas A Simonetto, David Rushlow, Kan Liu

|Dec 17, 2025
Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial.

Douglas A Simonetto, David Rushlow, Kan Liu

|Sep 11, 2025
Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE-303 Open-Label Study.

James E Ip, Benoit Coutu, John H Ip

Pageof 11

Frequent Collaborators

18 joint publications

Paul Friedman

16 joint publications

Zachi I Attia

10 joint publications

Xiaoxi Yao

9 joint publications

Suraj Kapa